Daily Dose - Jul 22nd, 2025
Daily Dose |
View online
July 22, 2025
AstraZeneca pledges $50B investment in US manufacturing, R&D amid Trump tariff threat
CEO Pascal Soriot said the company’s capital expenditure will support its goal of reaching $80 billion in revenue by 2030, with 50% generated in the United States.
Read More
Biogen to invest $2B in North Carolina manufacturing expansion
The biotech company plans to expand fill-finish, automation and antisense oligonucleotide capabilities at its Research Triangle Park site.
Read More
Sanner opens first US manufacturing site to support pharma packaging growth
The North Carolina facility features cleanrooms, injection molding, and lab services tailored to the healthcare sector, according to the company.
Read More